- Home
- DSGN vs AFRI Comparison
DSGN vs AFRI Comparison
Compare DSGN & AFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- AFRI
- Stock Information
- Founded
- DSGN 2017
- AFRI 1943
- Country
- DSGN United States
- AFRI Gibraltar
- Employees
- DSGN N/A
- AFRI N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- AFRI Packaged Foods
- Sector
- DSGN Health Care
- AFRI Consumer Staples
- Exchange
- DSGN Nasdaq
- AFRI Nasdaq
- Market Cap
- DSGN 208.9M
- AFRI 207.7M
- IPO Year
- DSGN 2021
- AFRI N/A
- Fundamental
- Price
- DSGN $5.85
- AFRI $8.67
- Analyst Decision
- DSGN
- AFRI
- Analyst Count
- DSGN 0
- AFRI 0
- Target Price
- DSGN N/A
- AFRI N/A
- AVG Volume (30 Days)
- DSGN 167.2K
- AFRI 12.5K
- Earning Date
- DSGN 11-06-2025
- AFRI 04-30-2025
- Dividend Yield
- DSGN N/A
- AFRI N/A
- EPS Growth
- DSGN N/A
- AFRI N/A
- EPS
- DSGN N/A
- AFRI N/A
- Revenue
- DSGN N/A
- AFRI $274,223,000.00
- Revenue This Year
- DSGN N/A
- AFRI N/A
- Revenue Next Year
- DSGN N/A
- AFRI N/A
- P/E Ratio
- DSGN N/A
- AFRI N/A
- Revenue Growth
- DSGN N/A
- AFRI N/A
- 52 Week Low
- DSGN $2.60
- AFRI $7.47
- 52 Week High
- DSGN $7.77
- AFRI $11.74
- Technical
- Relative Strength Index (RSI)
- DSGN 55.18
- AFRI 61.86
- Support Level
- DSGN $5.65
- AFRI $8.10
- Resistance Level
- DSGN $6.65
- AFRI $8.87
- Average True Range (ATR)
- DSGN 0.49
- AFRI 0.40
- MACD
- DSGN -0.05
- AFRI -0.01
- Stochastic Oscillator
- DSGN 50.40
- AFRI 58.70
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About AFRI Forafric Global PLC
Forafric Global PLC is engaged in production and sale of a variety of wheat flours, Semolina and Pasta and Couscous in Morocco and in more than 45 countries. The two main brands in Morocco are MAYMOUNA and TRIA. The company derives majority of its revenue from Soft wheat.